Access Vascular’s HydroPICC Dual-Lumen 5-F Catheter Used in First Patient

December 12, 2022—Access Vascular, Inc. (AVI) announced the first use of the company’s HydroPICC dual-lumen 5-F catheter, which is made from the company’s hydrophilic biomaterial featuring Mimix technology. In May 2022, AVI announced FDA clearance of the device.

AVI advised that the HydroPICC dual-lumen device will be made available in multiple kit configurations during the coming weeks as the newest addition to the company’s expanding family of vascular access devices. AVI plans to continue expansion of its portfolio by adding more peripheral intravenous and central line options.

The biomaterial used in AVI’s suite of vascular access devices is designed to avoid the complications seen in use of polyurethane catheters and has demonstrated a significant reduction in complications such as occlusions, deep vein thrombosis, and phlebitis, stated the company.

Howard Roth, MD, performed the initial procedure with the device at Riverside Medical Center in Kankakee, Illinois, which is a Magnet-designated level-two trauma hospital just outside of the Chicago area. The device was inserted in a patient experiencing complications with an existing polyurethane catheter.

“We frequently encounter patients with vascular access complications or polyurethane catheters that need to be replaced and are pleased to have a biomaterial alternative,” commented Dr. Roth in the company’s press release. “We want our patients to focus on getting healthier, and by reducing complications associated with their vascular access device, we can accelerate their treatment and eventual recovery.”